Efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis: A systematic review and meta-analysis of randomized controlled trials
International Immunopharmacology · 2025-03 · 149 · 114223
DOI: 10.1016/j.intimp.2025.114223 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Immunopharmacology, 2025-03. Verfasst von Xiaoying Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gerontology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, China. Hauptthemen laut MEDLINE: Arthritis, Gouty, Drugs, Chinese Herbal. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Department of Sichuan Province, Sichuan Provincial Administration of Traditional Chinese Medicine.
Abstract (Originalsprache)
OBJECTIVE: The present study aimed to comprehensively assess the efficacy and safety of Chinese herbal compounds in the management of acute gouty arthritis (AGA). MATERIALS AND METHODS: A systematic search was performed across multiple databases, including PubMed, The Cochrane Library, Embase, Web of Science, CBM, CNKI, VIP, and Wanfang, from their inception until December 1, 2024, to identify relevant randomized controlled trials (RCTs) involving Chinese herbal compounds for AGA. Two independent researchers were responsible for the retrieved literature screening, data extraction, and quality evaluation. A meta-analysis of RCTs that fulfill the inclusion criteria will be executed utilizing Stata 14.0 software. The quality of the outcomes will be assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE). RESULTS: A total of 28 studies, encompassing 2100 participants, were included in the analysis. The meta-analysis showed that compared with conventional Western medicine, Chinese herbal compounds significantly enhance the overall efficacy of AGA treatment (RR = 1.11, 95 %CI (1.05, 1.16), P < 0.00001; Level of evidence: very low). It also demonstrated improvements in the Visual Analogue Scale (VAS) (SMD = -1.46, 95 %CI(-2.17, -0.75), P < 0.00001; Level of evidence: very low), serum uric acid levels (SMD = -0.67, 95 %CI (-1.00, -0.33), P < 0.00001; Level of evidence: very low), blood sedimentation levels (SMD = -0.71, 95 %CI (-1.08, -0.33), P < 0.00001; Level of evidence: very low), C-reactive protein (CRP) levels (SMD = 0.89, 95 %CI(-1.33, -0.45), P < 0.00001; Level of evidence: very low), and the traditional Chinese medicine syndrome score(SMD = -0.93, 95 %CI (-1.37, -0.49), P < 0.00001; Level of evidence: very low). Additionally, a reduced incidence of adverse effects was noted (RR = 0.26, 95 %CI (0.18, 0.39), P < 0.00001; Level of evidence: moderate). Subgroup analysis revealed that regardless of whether the treatment duration was less than or more than 1 week, Chinese herbal compounds were effective in improving the total effective rate of AGA treatment, VAS scores, serum uric acid levels, blood sedimentation levels, CRP levels, and Traditional Chinese medicine symptom scores, while simultaneously decreasing the occurrence of adverse reactions. CONCLUSION: Chinese herbal compounds demonstrated superior efficacy and safety compared to conventional Western medicine in treating AGA. However, further validation through multicenter, high-quality RCTs is warranted to strengthen this conclusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gerontology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou 646000, China.
- Department of Rheumatism and Immunity, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu 610072, China.
- Department of Acupuncture and Moxibustion, Jiading Hospital of Traditional Chinese Medicine, Shanghai 201800, China.
- Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
- School of Health & Biomedical Sciences, RMIT University - Bundoora Campus, Melbourne 3083, Australia.
- School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, China.
Förderung
- Science and Technology Department of Sichuan Province
- Sichuan Provincial Administration of Traditional Chinese Medicine
Zitieren
APA
Zhao, X., Fan, Y., Sun, J., Chen, H., Nwafor, E. O., Wang, H., Wu, J., & Jiang, Y. (2025). Efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis: A systematic review and meta-analysis of randomized controlled trials. International Immunopharmacology, 149, 114223. https://doi.org/10.1016/j.intimp.2025.114223
Vancouver
Zhao X, Fan Y, Sun J, Chen H, Nwafor EO, Wang H, et al. Efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis: A systematic review and meta-analysis of randomized controlled trials. International Immunopharmacology. 2025;149:114223. doi:10.1016/j.intimp.2025.114223
BibTeX
@article{Zhao2025,
author = {Zhao, Xiaoying and Fan, Yihua and Sun, Jiya and Chen, Huixin and Nwafor, Ebuka-Olisaemeka and Wang, Hongting and Wu, Jianming and Jiang, Yu},
title = {Efficacy and safety of Chinese herbal compound in the treatment of acute gouty arthritis: A systematic review and meta-analysis of randomized controlled trials},
journal = {International Immunopharmacology},
year = {2025},
volume = {149},
pages = {114223},
doi = {10.1016/j.intimp.2025.114223}
}
EUVIMED